Researchers investigated the multi-omic landscape of steatosis-to-NASH progression in mice

The global prevalence of nonalcoholic fatty liver disease (NAFLD) is estimated to be > 25% and will continue to rise. NAFLD comprises a spectrum of liver disorders ranging from simple steatosis (NAFL) to nonalcoholic steatohepatitis (NASH). While NAFL is generally considered as to be a benign condition, NASH is prone to develop into severe end-stage liver diseases. However, the molecular mechanisms of steatosis-to-NASH progression remain poorly understood.

Using two models of diet-induced NAFL and NASH mice, researchers from Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and the First Affiliated Hospital of Anhui Medical University and other collaborators have worked together to present comprehensive multi-omic profiles to identify genes, non-coding RNAs, proteins, and plasma metabolites involved in steatosis-to-NASH progression. This study entitled ‘A multi-omic landscape of steatosis-to-NASH progression’ is published online in Life Metabolism on 2 Dec 2022.

In this study, using two periods of HFHC diet-feeding, the authors performed a large-scale integrative analysis of liver tissues from NAFL and NASH mice with their age-matched normal controls. Overall, the multi-omics study captured 176 mRNAs, 1131 lncRNAs, 48 miRNAs, 295 proteins, and 53 plasma metabolites that are altered in NAFL mice compared to the age-matched normal mice. Meanwhile, 1745 mRNAs, 5161 lncRNAs, 146 miRNAs, 674 proteins, and 82 plasma metabolites were altered in NASH mice compared to the age-matched normal mice. Through comparisons of these alterations in two mouse models, a total of 1630 mRNAs, 4547 lncRNAs, 110 miRNAs, 500 proteins, and 46 plasma metabolites were specifically altered in NASH mice compared to NAFL mice. Thus, this study provides a valuable resource to explore the molecular mechanisms of steatosis-to-NASH progression.

In addition, through transcriptomic analysis, the authors found that growth differentiation factor (GDF3) was specifically up-regulated in the livers and plasma of NASH mice. In agreement, plasma GDF3 concentrations were markedly increased in patients with NASH compared to patients with NAFL or healthy individuals. Plasma GDF3 levels were strongly associated with the NAFLD activity score (NAS) and individual histologic features, including steatosis, ballooning, and lobular inflammation (Figure 1). The authors further evaluated the diagnostic potential of circulating GDF3, which demonstrated that it could be a non-invasive diagnostic biomarker for NASH patients with high accuracy (AUROC = 0.90).

Collectively, this study explored the molecular characterization of steatosis-to-NASH progression in mice through a large-scale system biology approach, which may provide a valuable resource to explore the molecular mechanisms of NASH progression. Moreover, GDF3 might be considered as a potential non-invasive diagnostic for NASH patients, although further studies are required for explore its role in NASH progression.

###

Reference: Liping Xiang et al. (2022). A multi-omic landscape of steatosis-to-NASH progression. Life Metabolism. https://doi.org/10.1093/lifemeta/loac034.

About Higher Education Press

Founded in May 1954, Higher Education Press Limited Company (HEP), affiliated with the Ministry of Education, is one of the earliest institutions committed to educational publishing after the establishment of P. R. China in 1949. After striving for six decades, HEP has developed into a major comprehensive publisher, with products in various forms and at different levels. Both for import and export, HEP has been striving to fill in the gap of domestic and foreign markets and meet the demand of global customers by collaborating with more than 200 partners throughout the world and selling products and services in 32 languages globally. Now, HEP ranks among China’s top publishers in terms of copyright export volume and the world’s top 50 largest publishing enterprises in terms of comprehensive strength.

About Life Metabolism

Life Metabolism is a fully open access, peer-reviewed journal that publishes one volume per year online, providing a platform for the publication of works of high significance and broad interest in all areas of metabolism. Life Metabolism welcomes several different article types, including original article, review article, research highlight, letter, editorial, perspective, and so on. Once a paper is accepted, Life Metabolism can publish a precopyedited, preproofed version of the paper online within 48 hours of receiving a signed licence, and this will be replaced by a copyedited, proofed version of the paper as soon as it is ready. The Editors-in-Chief are professors Peng Li at Tsinghua University and John R Speakman at University of Aberdeen, UK. In the first three years, there will be no publication costs for publishing in Life Metabolism, and Open Access fees will be waived.